These findings are in line with prior studies, such as the report by Jiang et al., which demonstrated that TOB1‐AS1 inhibits migration and proliferation in gastric carcinoma via the miR‐23a/NEU1 axis [10], and another showing its tumor‐suppressive role in esophageal cancer [24]. This evidence concerns the gene NEU1 and esophageal cancer.